Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
6.88
+0.33 (5.04%)
At close: Nov 6, 2025, 4:00 PM EST
6.87
-0.01 (-0.15%)
After-hours: Nov 6, 2025, 4:10 PM EST
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $391.8 million as of November 6, 2025. Its market cap has increased by 23.57% in one year.
Market Cap
391.80M
Enterprise Value
165.07M
1-Year Change
23.57%
Ranking
Category
Stock Price
$6.88
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $391.80M, a decrease of -82.24%. That is a compound annual growth rate of -31.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 373.01M | 6.77% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | 2.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 838.71B |
| Johnson & Johnson | 447.98B |
| AbbVie | 384.79B |
| UnitedHealth Group | 293.79B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 215.59B |
| Merck & Co. | 214.58B |